The emerging treatment of the medication represents a exciting breakthrough in the management of type 2 diabetes. Different to existing therapies, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatide-peptide043695.verybigblog.com/40783432/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment